Biogen Message Board - Msg: 238024

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 179.89

+2.1%

Jan 30 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hong-Lee Yu who wrote (3)	8/23/1996 7:23:00 AM
From: Harold Engstrom	of 1686

Hong-Lee Yu: 30,000 patients does seem conservative for the end of the year. The company reportedly is adding well in excess of 1,000 patients per week, and with european approvals pending during the first half of next year, the company could have more than 150,000 patients by the end of '97. That would add up to an annual revenue pace of roughly $1.2B, not including royalty income. Saw estimates for earnings next quarter of $0.55 and for subsequent quarters of slightly declining earnings. I think that is extremely unlikely. Biogen should handily beat those expectations (they are starting with a $0.605 base for next quarter - they have already announced that they are excercising tax credits for the next couple of quarters). Can't explain the rally in the absence of news. If anyone has any info, it would be great to hear it.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next